|Interesting uptick on the share price over the past few days. Mind you, it's only really recovering from the recent drops. There doesn't appear to be anything on the wires, and it could well just be another blip in a pretty volatile SP, but maybe they are finally hitting that elusive cash-flow break even position? The UK market for Accoya remains very strong from what I hear, but I have no idea about growth in other markets.|
|Accsys Technologies Signs Up BP Ventures To Tricoya Consortium
|Proactive Investors interview with Paul Clegg on the 14th December.
I agree that we need to know more before making an informed decision . I will try to find out more.|
|That's not good news.|
|IMHO, it's pretty difficult to take any firm position, positive or negative, on this latest news, without a great deal more information, which I doubt we'll get. The one ongoing positive is that, in the UK at least, Accoya is still selling very well indeed. The higher production is currently certainly required, but, as you rightly imply, at what cost?|
|So, the interim results for the 6 months ended 30th September are due next Monday, 30th November. It'll be interesting to see if the company will have now reached a cash-flow break even position. This was clearly the hope for the board to happen at some point this year.|
|26 November 2015
NYSE Euronext Amsterdam: AXS
26 November 2015
ACCSYS TECHNOLOGIES PLC
("Accsys" or "the Company")
Solvay and Accsys enhance their collaboration to accelerate marketing, sales and manufacturing of Accoya(R)
Accsys, the chemical technology group, focused on the acetylation of wood, today is pleased to announce details of a new agreement with Solvay Acetow Gmbh ("Solvay"), to refine the relationship between the two parties for the licensing, marketing and manufacturing of Accoya(R) . This new agreement provides the framework and funding for a significant increase in the manufacturing capacity in Arnhem.
Solvay will purchase a minimum 76,000 cubic metres of Accoya from the Arnhem plant over the period from 2016 to 2020 (the "offtake commitment") and as a result of the increased manufacturing capacity in Arnhem and consequent greater sales capacity, under the new agreement Solvay will review the optimal timing to construct its 63,000 cubic metres Accoya manufacturing plant.
The enhanced relationship with Solvay will benefit both parties, with the increased manufacturing capacity and resulting sales expected to be achieved for Accoya in a faster timescale than would otherwise have been possible.
Accsys will double the existing manufacturing capacity at its Arnhem site in stages, up to 80,000 cubic metres per annum from 40,000 cubic metres. The initial incremental 20,000 cubic metres capacity is expected to come on stream in mid-2017.
The licence agreement covering Europe has been amended to provide increased royalties to Accsys and the return to Accsys of the selling rights for 20 European countries.
Accsys will provide sales and marketing services to Solvay on agreed terms in respect of Solvay's exclusive European territories.
A combination of loans and fees from Solvay, in addition to those due under the offtake commitment, will fund the majority of the initial increase in manufacturing capacity at Arnhem, with the balance to be met by Accsys' own resources, including the possible sale and leaseback of land at Arnhem.
Paul Clegg, CEO of Accsys said: "We are pleased to be able to cement our relationship with Solvay through this agreement to expand our Accoya(R) manufacturing capacity and Solvay's commitment to purchase significant volumes from Accsys over the coming years. This is an exciting step in the development of our business and is further evidence of the fruits of our strategy to maximise returns from our technology platform and resultant product offerings."
These agreements allow the market development of Accoya to continue and optimises the roll out of manufacturing capacity under its partnering program with Solvay, increasing the certainty of supply for Accoya customers and users. It also enables Accsys to continue to develop global markets effectively, building on the expertise that it has developed over the last few years.
Accsys's interim results for the six months ended 30 September 2015 will be released on 30 November 2015.
|Most would agree with you, but what can be done, realistically. CEOs know this but are so selfish they don't care what anybody thinks, as long as they are impotent to change it.|
|Looked in here. I understand the science and can see it being a success. When I see Clegg paying himself £916k/yr for an as yet loss making company with a M.Cap of £57m that's way out of place.|
|The only thing that I can see that could remotely be connected to this drop was the announcement yesterday of an Extraordinary General Shareholders’ Meeting by Solvay, which is scheduled to take place on October 23rd. It's purpose, as far as I can see, is for the directors to propose to shareholders to grant it the authorization to increase the share capital of the company with a view to financing or refinancing the acquisition of Cytec in the U.S.
Of course I could be completely picking at straws here. :-)|
|Thanks TW- hope you're right. Promising reversion of most of yesterday's loss ... At least thus far today|
|I see absolutely no reason why the share price should have dropped so much today. It's similar to the weird, unexplained drop we saw just after the release of the preliminary results 2014/15, from where it's since recovered.
All I know from people in the UK distribution business is that Accoya is still flying off the shelf and gaining more market share.
"Some folk know more than we do?" Maybe! However, I really don't see it as a factor, and, as you rightly say, the share price is prone to big swings. IMHO they should still be heading for a cash-flow break even position this year, which should boost the share price further.
However, should there be a major upset due, then all bets are of course off.|
|Looks very serious but this share has swung about a lot recently, dropping sharply one day only to rise quickly to be where it was. If it does not show some signs of recovery tomorrow ( irrespective of market) I will begin to fret.
Still it is strange on such a big up day in the market.|
|Sea of red and 8.5% drop today... Some folk know more than we do??|
|Went to see my local joiner today. Very busy two man business. He informs me that more and more people are asking for Accoya. he has experimented soaking it in water and is very impressed with its properties as it appears totally water resistant and does not change shape or swell.
When does the factory in Freiburg start production?
Are they building a plant in the USA?
Will they reach profitability this year?|
|No special reason I just like the story.|
|Do you have any special reason for buying Capt? Are you new to this or topping up?
I bought twice at about 65p. Saw them get to 80pbut they have struggled since results. However, I have always been in profit so not complaining.|
|Bought some of these today|
|As is often the case, I'm guessing a mention of the stock somewhere in the media. However, nothing showing up on the radar yet.|
|I too was hoping for some insight that I did not have to explain the leap. Maybe folk have realised that the fall since tha results was much overdone, but the movement in price was unexpected by me.|
|Interesting jump of 10% On share price today. Any ideas why?|
|Preliminary results 2014/15:
Generally pretty positive overall IMHO, although not cash flow positive yet.|
|The Accys Technologies website is advising that the preliminary results for the year ended 31st March, 2015 will be announced on the 16th June.
I've topped up a few shares on the recent dip as I'm hoping that maybe they will have now reached a cash-flow break even position in Q4 2014/15. This was clearly the hope in the Q3 2014/15 update.|